Grant Details

General Overview

Grant Information

Grant name: Integrating Biospecimen Science Approaches into Clinical Assay Development

Funding organization: National Institutes of Health (NIH), National Cancer Institute (NCI)

Total funding amount: $250,000 per year

Duration: Maximum of 5 years

Primary objective: To investigate and mitigate challenges in clinical assay development due to preanalytical variability in biospecimens.

Key stakeholders: Clinical researchers, academic and private sector scientists.

Significance: Aims to improve biomarker clinical assay development through standardization of biopsy handling practices.

Grant frequency: Recurring.

Organizational Aspects

Eligible Organization Types

Higher Education Institutions

Public/State Controlled Institutions of Higher Education

Private Institutions of Higher Education

Nonprofits Other Than Institutions of Higher Education

For-Profit Organizations

Small Businesses

Local Governments

State Governments

County Governments

City or Township Governments

Indian/Native American Tribal Governments (Federally Recognized)

Indian/Native American Tribal Governments (Other than Federally Recognized)

Foreign Organizations

Specific Qualifications

Organizations must complete registrations with SAM, eRA Commons, and Grants.gov.

Principal Investigators must have an eRA Commons account.

Scope and Focus

Primary Focus Areas

Research on preanalytical variability in tumor tissue biopsies and blood biospecimens.

Improvement of biomarker assay reliability.

Expected Outcomes

Evidence-based standardization of biospecimen handling practices.

Improved understanding of biomarker quantification.

Technical Details

Technical Expertise Requirements

Multidisciplinary teams including pathologists, oncologists, radiologists, and molecular biologists.

Financial Structure

Budget and Funding

Application budgets are limited to $250,000 direct costs per year.

No cost-sharing is required.

Timeline and Implementation

Key Dates

Open Date: January 04, 2025

Application Due Dates: Various dates including June 04, 2025, September 10, 2025, February 04, 2026, and others until September 11, 2027.

Compliance and Requirements

Regulatory Compliance

Must comply with NIH Grants Policy Statement and other federal regulations.

Application Process

Submission Instructions

Applications must be submitted electronically via Grants.gov.

Follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.

Grant Details

cancer tumor biospecimen clinical research biomarker healthcare research medtech
Integrating Biospecimen Science Approaches into Clinical Assay Development
PAR-25-325
NIH Grants
EDU NGO ENTERPRISE PUBLIC RESEARCH OTHER
US
HEALTHCARE OTHER
DEVELOPMENT OTHER
0-10 11-50 51-250 251-500 500+
SDG3
FUNDING RESEARCH_DEVELOPMENT
None
250000.00
250000.00
250000.00
USD
100.00
Sept. 11, 2027, 10 p.m.
Not specified